🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

10 recruiting trials

for Soft Tissue Sarcoma of the Trunk and Extremities

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma NCT07169344Phase 24 sites📍 Bergen📍 Oslo📍 Tromsø Oslo University Hospital · Tests: preoperative, Quality of life, Functional outcome Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation NCT07615049Phase 367 sites📍 Birmingham📍 Anaheim📍 Antioch SWOG Cancer Research Network · Tests: 3-Dimensional Conformal Radiation Therapy, 3-Dimensional Conformal Radiation Therapy, Biospecimen Collection, Computed … Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas NCT06422806Phase 3269 sites📍 Phoenix📍 Tucson📍 Tucson National Cancer Institute (NCI) · Tests: Biospecimen Collection, Diagnostic Imaging Testing, Doxorubicin, Echocardiography Test, Multigated Acquisition Scan Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the Limbs or Trunk Wall NCT07507773Phase 21 site📍 Lille Centre Oscar Lambret · Tests: Moderately hypofractionated neoadjuvant radiotherapy Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma. NCT07173972Phase 22 sites📍 Bergen📍 Oslo Oslo University Hospital · Tests: Definitive radiotherapy Fluorescence-Guided Optimization of Sarcoma Margins NCT07134192NA2 sites📍 Aarhus N📍 Copenhagen University of Aarhus · Tests: Fluorescent-guided Surgery Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma NCT06498648Phase 1, Phase 21 site📍 Houston National Cancer Institute (NCI) · Tests: Abemaciclib, Biopsy Procedure, Biospecimen Collection, Computed Tomography, Docetaxel Individualized Prehabilitation for Enhancing Recovery and Surgical Outcomes in Patients Undergoing Radiotherapy and Surgery for Soft Tissue Sarcoma NCT05526417NA1 site📍 Scottsdale Mayo Clinic · Tests: Computed Tomography, Educational Intervention, Magnetic Resonance Imaging, Physical Therapy, Questionnaire Administrati… Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients NCT07432932n/a1 site📍 London Royal Marsden NHS Foundation Trust · Tests: Observational Translational Study Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities NCT04751409Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Chest Radiography, Computed Tomography, Follow-Up, Follow-Up, Imaging Technique
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy